Determinants for the drug release from T-0128, camptothecin analogue-carboxymethyl dextran conjugate (Q73259010)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Determinants for the drug release from T-0128, camptothecin analogue-carboxymethyl dextran conjugate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

M Harada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

H Sakakibara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Yano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Suzuki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Okuno

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

Journal of Controlled Release

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

399-412

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Changing views of the role of matrix metalloproteinases in metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Cell surface complex of cathepsin B/annexin II tetramer in malignant progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Cathepsin B, Cathepsin H, and cathepsin L

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

CA074 methyl ester: a proinhibitor for intracellular cathepsin B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Inhibitions of cathepsin B and cathepsin L by E-64 in vivo. II. Incorporation of [3H]E-64 into rat liver lysosomes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Tumor cell membrane cathepsin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Antitumor effects and toxicities of carboxymethylpullulan-peptide-doxorubicin conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Cathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Macrophage-mediated activation of camptothecin analogue T-2513-carboxymethyl dextran conjugate (T-0128): possible cellular mechanism for antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

A model to explain the pH-dependent specificity of cathepsin B-catalysed hydrolyses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Chromophoric and fluorophoric peptide substrates cleaved through the dipeptidyl carboxypeptidase activity of cathepsin B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Polymer-bound camptothecin: initial biodistribution and antitumour activity studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Evaluation of the efficiency of targeting of antitumor drugs: simulation analysis based on pharmacokinetic/pharmacodynamic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900321-7

7 January 2021

10.1016/S0168-3659(00)00321-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11102680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference